Agrizy Launches Phytochemistry R&D Lab to Bridge India's Herbal Farms with Global Nutraceutical Standards

Bengaluru/New Delhi — Agrizy, India's leading technology-driven Contract Research, Development, and Manufacturing Organisation (CRDMO) serving global food and beverage and wellness brands, has unveiled its new Phytochemistry R&D Laboratory. The facility is purpose-built to produce high-performance botanical ingredients while improving value distribution across India's herbal supply chain — from cultivation at the farm level all the way through to finished, market-ready products.

Strategically positioned to serve the $650 billion global nutraceutical market, the laboratory is designed to meet rising international demand for scientifically validated, regulatory-compliant botanical ingredients. With global buyers increasingly prioritising provenance, clinical validation, safety assurance, and supply chain transparency, India's herbal sector is under growing pressure to evolve from a raw material supplier into a science-backed ingredient powerhouse.

Addressing a Structural Gap in India's Herbal Value Chain

India's herbal farming communities have long served as the foundation of the global wellness industry, supplying raw botanical materials at scale. Yet value realisation at the source has remained consistently limited. The underlying reasons are well-documented: fragmented procurement networks, price-driven aggregation models, and inconsistent quality standards have historically kept farmers from accessing premium markets.

This challenge is becoming more acute as nutraceutical brands worldwide tighten their sourcing criteria. Buyers now demand detailed documentation of ingredient origin, marker compound concentrations, contaminant testing results, and compliance with major regulatory frameworks. India's competitive advantage in biodiversity and raw material abundance means little if those inputs cannot be translated into globally acceptable ingredient specifications.

Agrizy's integrated CRDMO model was conceived to directly address this structural disconnect. By connecting farm-level cultivation practices to international quality infrastructure, the company is creating a pipeline that transforms agricultural output into validated, compliant, and commercially viable botanical ingredients.

What the Phytochemistry R&D Laboratory Does

The newly launched facility is equipped with a comprehensive suite of laboratory instruments and equipment designed to extract, isolate, and purify phyto-ingredients from a diverse range of medicinal plants. Its core functions span ingredient development, raw material authentication, herbal extract standardisation, and phytochemical evaluation.

A key technical differentiator of the laboratory is its rigorous approach to quality validation. Every ingredient developed within the facility undergoes multi-stage fingerprinting and method validation aligned with United States Pharmacopoeia (USP) standards and international pharmacopeial benchmarks. This ensures that potency and purity claims are reproducibly documented, scientifically defensible, and audit-ready for global regulatory submissions.

Beyond basic extraction and standardisation, the lab also develops advanced delivery systems. These include phytosomes, nanoformulations, and water-soluble botanical formats engineered to improve bioavailability, stability, and functional performance. The delivery formats are tailored to work across a wide range of product categories, including capsules, tablets, functional beverages, and nutraceutical food formats — giving brand partners flexibility in how they incorporate Agrizy's ingredients into finished products.

Leadership and Scientific Expertise

The laboratory is directed by Dr Laxman Sawant, a PhD-qualified phytochemist with more than 16 years of hands-on experience in the botanical ingredient and nutraceutical sector. His career spans senior roles at some of India's most respected names in the space, including Dabur, Himalaya Drug Company, Piramal Life Sciences, Natural Remedies, and OmniActive Health Technologies.

Dr Sawant leads a multidisciplinary team whose collective expertise exceeds 100 years across botanical research, analytical chemistry, formulation science, and regulatory affairs. This depth of experience allows the lab to operate not just as a testing facility, but as a full-spectrum ingredient innovation engine.

Spoken directly on the significance of the investment, Dr S. Vijaya Kumar, CEO of Wellness at Agrizy, said: "This investment enhances our capability to develop scientifically validated herbal ingredients that comply with global standards and deliver consistent performance.

By combining traditional botanical knowledge with advanced research, extraction technologies, and strong quality systems, we are creating standardized ingredients that meet international expectations. This demonstrates our commitment to establishing credibility and long-term value within the nutraceutical ecosystem."

Quality Control That Begins at the Farm

One of the most distinctive elements of Agrizy's model is how far upstream its quality systems extend. Rather than applying quality controls only at the processing or manufacturing stage, Agrizy establishes phytochemical and marker-based specifications directly at the farm level.

The company collaborates with farmers, Farmer Producer Organisations (FPOs), and Village Level Aggregators (VLAs) across Karnataka, Maharashtra, Tamil Nadu, and West Bengal — all regions with established reputations for producing key botanicals. These include turmeric, coleus, bacopa, and ashwagandha, each of which commands significant demand in international nutraceutical markets.

By embedding Ayurvedic pharmacognosy within a modern analytical validation framework, Agrizy treats farms as the first stage of a quality-controlled ingredient pipeline. Authenticated plant identification, cultivation protocols tailored to phytochemical yield, and systematic contaminant management are all implemented at the source. This approach fundamentally shifts procurement logic — from volume-driven buying to specification-based sourcing — creating more stable and higher-value demand for growers while simultaneously reducing adulteration risk and improving ingredient traceability.

Priority Ingredients and Commercial Progress

Agrizy's initial research and development focus is concentrated on botanicals with established global demand and strong market growth trajectories. These include Curcumin, targeted at inflammation and metabolic health applications; Ashwagandha, positioned for adaptogenic and cognitive support; Boswellia, developed for joint health formulations; and Bacopa and Gymnema, applied across cognitive and metabolic health categories.

Importantly, Agrizy's platform is already operational rather than simply aspirational. Early commercial initiatives for Curcumin and Coleus are actively underway, signalling that the company's ingredient pipeline has moved beyond the research phase and into live market engagement.

Agrizy currently holds 21 trademarks for its proprietary products and has filed two patents, with additional filings in progress. These intellectual property assets reflect the company's commitment to building proprietary scientific differentiation within a competitive global ingredient market.

Regulatory Readiness Built Into Every Development Cycle

For global brands sourcing botanical ingredients, regulatory compliance is increasingly a make-or-break factor. Agrizy has integrated regulatory readiness at every stage of its development process. The laboratory generates complete technical dossiers supporting compliance with standards set by India's FSSAI and AYUSH regulatory bodies, as well as the US FDA and the European Food Safety Authority (EFSA).

This built-in regulatory infrastructure enables Agrizy's partner brands to accelerate product registration and market entry, while substantially reducing the delays and third-party documentation costs that typically slow down new product launches. Development cycles are structured to run between three and six months, covering everything from initial concept validation through formulation development and on to full commercialisation support.

A Scalable Model That Creates Value at Every Level

Agrizy's integrated model is designed to generate aligned value across all stakeholders in the botanical supply chain. Farmers benefit from premium, specification-driven demand that rewards quality over volume. Brands gain access to validated, regulatory-compliant ingredients backed by documented science. And global markets receive high-quality botanical products with verifiable traceability and rigorous research credentials.

Founded in 2021 by Vicky Dodani and Saket Chirania, Agrizy is a Series A-funded company that functions as an end-to-end backend catalyst for global F&B and wellness brands. Its operational scope covers the complete product lifecycle — from concept ideation and R&D-led formulation development through ingredient sourcing, manufacturing, and global fulfilment. The company integrates GenAI capabilities, in-house R&D expertise, tech-enabled quality systems, and processing infrastructure to build what it describes as an intelligence-led backbone for the global F&B and wellness industry.

Today, Agrizy works with more than 300 global food, beverage, and wellness brands across more than 20 countries. The company is backed by a strong investor group that includes Accion, Ankur Capital, Capria, Omnivore, and Thai Wah Ventures.